LENZ has been shown to be safe in clinical settings following administration to 125 patients in multiple indications, including severe respiratory conditions and leukemia, with no serious or adverse events.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.